Reyataz (atazanavir) is a small molecule pharmaceutical. Atazanavir was first approved as Reyataz on 2003-06-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Antivirals: HIV protease inhibitors (saquinavir type)|